Aaron M Milstone

Author PubWeight™ 43.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics 2010 1.88
2 Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children. J Pediatr 2010 1.54
3 Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect Immun 2009 1.51
4 Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. Clin Infect Dis 2013 1.50
5 Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis 2011 1.36
6 Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014 1.24
7 Detecting respiratory viruses in asymptomatic children. Pediatr Infect Dis J 2012 1.19
8 High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2014 1.18
9 Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol 2014 1.14
10 An outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2012 1.10
11 Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr 2013 1.07
12 Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients. Pediatrics 2012 1.07
13 Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2013 1.06
14 Empirical power and sample size calculations for cluster-randomized and cluster-randomized crossover studies. PLoS One 2012 1.05
15 Ventilator-associated tracheitis in children: does antibiotic duration matter? Clin Infect Dis 2011 1.04
16 Fatal infection caused by Cupriavidus gilardii in a child with aplastic anemia. J Clin Microbiol 2010 1.02
17 Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010 1.01
18 Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort. J Clin Virol 2012 1.00
19 Blood concentrations of chlorhexidine in hospitalized children undergoing daily chlorhexidine bathing. Infect Control Hosp Epidemiol 2011 0.93
20 Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agencies. Jt Comm J Qual Patient Saf 2013 0.92
21 Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients. BMC Pediatr 2010 0.91
22 Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing? Clin Infect Dis 2012 0.89
23 Impact of colonization pressure and strain type on methicillin-resistant Staphylococcus aureus transmission in children. Clin Infect Dis 2013 0.87
24 Pediatric antimicrobial susceptibility trends across the United States. Infect Control Hosp Epidemiol 2013 0.85
25 Does the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia? Clin Infect Dis 2012 0.85
26 Fact, fiction, or no data: what does surveillance for methicillin-resistant Staphylococcus aureus prevent in the intensive care unit? Clin Infect Dis 2008 0.83
27 Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors. Pediatr Blood Cancer 2013 0.83
28 Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients. JAMA Pediatr 2013 0.82
29 Predictors of first recurrence of Clostridium difficile infections in children. Pediatr Infect Dis J 2014 0.82
30 The past, present, and future of healthcare‐associated infection prevention in pediatrics: catheter‐associated bloodstream infections. Infect Control Hosp Epidemiol 2010 0.81
31 Association of bacterial pneumonia and respiratory failure in children with community-acquired influenza infection. Pediatr Crit Care Med 2011 0.81
32 Risk factors for persistent methicillin-resistant Staphylococcus aureus colonization in children with multiple intensive care unit admissions. Infect Control Hosp Epidemiol 2013 0.80
33 Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014 0.80
34 Central line maintenance bundles and CLABSIs in ambulatory oncology patients. Pediatrics 2013 0.80
35 The prediction of complicated Clostridium difficile infections in children. Infect Control Hosp Epidemiol 2014 0.79
36 Bringing central line-associated bloodstream infection prevention home: catheter maintenance practices and beliefs of pediatric oncology patients and families. Jt Comm J Qual Patient Saf 2015 0.79
37 Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Pediatr Infect Dis J 2009 0.79
38 Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia. J Antimicrob Chemother 2013 0.79
39 Prolonged β-lactam infusion for Gram-negative Infections. Pediatr Infect Dis J 2011 0.78
40 Changes over time in caregivers' knowledge, attitudes, and behaviors regarding methicillin-resistant Staphylococcus aureus. J Pediatr 2011 0.77
41 Extended-interval aminoglycoside dosing in pediatrics. Pediatr Infect Dis J 2011 0.77
42 Failure of intravenous pentamidine prophylaxis to prevent pneumocystis pneumonia in a pediatric hematopoietic stem cell transplant (HSCT) patient. Pediatr Blood Cancer 2006 0.77
43 Postdischarge surveillance to identify subsequent methicillin-resistant Staphylococcus aureus infections in colonized children. Am J Infect Control 2013 0.75
44 Expanding the statistical toolbox: analytic approaches for cohort studies with healthcare-associated infectious outcomes. Curr Opin Infect Dis 2015 0.75
45 Central line-associated bloodstream infections in neonates with gastrointestinal conditions: developing a candidate definition for mucosal barrier injury bloodstream infections. Infect Control Hosp Epidemiol 2014 0.75
46 Epstein-Barr virus-associated central nervous system lymphoproliferative disease in a patient with acquired immunodeficiency syndrome responsive to highly active antiretroviral therapy. Clin Infect Dis 2008 0.75
47 Pseudomonas aeruginosa pre-septal cellulitis and bacteremia in a pediatric oncology patient. Pediatr Blood Cancer 2005 0.75
48 Is retinoid-induced osteopenia reversible? Arch Dermatol 2002 0.75
49 Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures? Clin Chem 2013 0.75
50 Creating a Pediatric Joint Council to Promote Patient Safety and Quality, Governance, and Accountability Across Johns Hopkins Medicine. Jt Comm J Qual Patient Saf 2017 0.75
51 The past, present, and future of healthcare‐associated infection prevention in pediatrics: viral respiratory infections. Infect Control Hosp Epidemiol 2010 0.75
52 Pediatric providers' acceptance of recommendations for routine rotavirus vaccination. Clin Pediatr (Phila) 2008 0.75